Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2018Journal of Dermatological Treatment

JAK-inhibitors in dermatology: current evidence and future applications

View Full Paper
Ask AI
Bookmark
Share

Authors

PCPiotr CiechanowiczARAdriana RakowskaMSMariusz Sikora

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ciechanowicz et al. (2018) studied this question.

synapsesocial.com/papers/69dbe45aeb8801008ea3c259https://doi.org/10.1080/09546634.2018.1546043
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata2016 · 352 citations
  2. 2IL-3 Induces Basophil Expansion In Vivo by Directing Granulocyte-Monocyte Progenitors to Differentiate into Basophil Lineage-Restricted Progenitors in the Bone Marrow and by Increasing the Number of Basophil/Mast Cell Progenitors in the Spleen2009 · 128 citations
  3. 3Signaling by STATs.2004 · 152 citations
  4. 4Local level of TGF-β1 determines the effectiveness of dexamethasone through regulating the balance of Treg/Th17 cells in TNBS-induced mouse colitis2018 · 11 citations